FDA Inspection 780431 — Eurofins Biopharma Product Testing, Denmark A/S
The FDA completed an inspection of Eurofins Biopharma Product Testing, Denmark A/S on March 30, 2012 in Glostrup. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 30, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Glostrup (Denmark)